You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

Article metrics

Article menu

Download PDFPDF

XML
Pleural Disease
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

 

Online download statistics by month:

Online download statistics by month: March 2020 to May 2023

AbstractFullPdf
Mar 202014016359
Apr 202010611082
May 2020706999
Jun 2020464417
Jul 202042399
Aug 2020403512
Sep 2020666210
Oct 2020656022
Nov 2020736911
Dec 2020535210
Jan 2021767218
Feb 2021605422
Mar 2021504915
Apr 2021494811
May 2021484710
Jun 2021524925
Jul 2021545217
Aug 2021434220
Sep 2021464329
Oct 2021434332
Nov 2021363419
Dec 2021504712
Jan 202232317
Feb 2022322913
Mar 2022323116
Apr 202237399
May 2022353313
Jun 2022444415
Jul 2022393611
Aug 2022353312
Sep 2022686851
Oct 202239387
Nov 2022373611
Dec 2022262717
Jan 2023333317
Feb 2023606016
Mar 2023342910
Apr 202322209
Total19131870795